dsRNA MOLECULES, SMALL INTERFERING RNA (pRNA) MOLECULES, COMPOUND, METHOD FOR OBTAINING dsRNA MOLECULES, PLASMID, HOST CELL, PEST CONTROL METHOD

AR135143A1Pending Publication Date: 2026-07-08SEMPRE AGTECH LTDA +1

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: ARP20240103652
Authority / Receiving Office: AR · AR
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2023-12-29
Filing Date: 2024-12-27
Publication Date: 2026-07-08

Application Information

Patent Timeline

29 Dec 2023

Priority

27 Dec 2024

Application

ARP20240103652

08 Jul 2026

Publication

AR135143A1

IPC: C12N15/113; C12N15/82; A01N63/60; A01P7/04

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.

Claims

The present invention relates to double-stranded RNA (dsRNA) molecules, compounds comprising dsRNA molecules, a method for obtaining dsRNA molecules, and methods for pest control in soybean-corn production systems. The dsRNA compound of the present invention exhibits an efficient and specific mode of action against insect pests due to its biotargeted nature, particularly in the control of brown stink bugs (Euschistus heros) and green-bellied stink bugs (Diceraeus melacanthus). Furthermore, it is sustainable, naturally non-toxic, non-allergenic, and non-virulent.

1. dsRNA molecules characterized in that they contain the synthetic sequences for dsRNA expression that activate the silencing of transcripts of selected genes of Trehalase II (TrehaII), Trehalose Transporter II (TreTran II), Transcription Initiation Factor TFIID Subunit 1 (TAF1) or at least one concatemer comprising a combination of such sequences.